Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX
Kewalramani Reshma sold 11,866 Vertex Pharmaceuticals Incorporated shares (Form 4)
Traded Nov 6, 2026 · Filed Nov 10, 2026
On Nov 6, 2026, Kewalramani Reshma (Director, CEO & President) sold 11,866 Vertex Pharmaceuticals Incorporated shares at US$531.53 for US$6.31M under a trading plan, leaving 86,471 shares. Filed Nov 10, 2026 (Form 4).
- Sold
- 11,866 shares
- Price
- US$531.53
- Value
- US$6.31M
- Holding after
- 86,471 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Common Stock | Sale | 11,866 | US$531.53 | 86,471 | Direct |
Source
Download original · View original at SEC
Related
- Vertex Pharmaceuticals Incorporated
- Kewalramani Reshma
- Vertex Pharmaceuticals Incorporated shareholders
- Form 4 · Thornberry Nancy · Nov 18, 2026
- Form 4 · Bhatia Sangeeta N. · Nov 18, 2026
- Form 4 · Wagner Charles F Jr · Nov 16, 2026
- Schedule 13G/A · Capital Research Global Investors · Nov 13, 2026
- Form 4 · Brennan Daniel J. · Oct 22, 2026